Pharmaceutical Patent Issues

Pirmais vāks
DIANE Publishing, 2000 - 291 lappuses
Witnesses: Michael Kantor, U.S. Trade Rep.; William Brock, former U.S. Trade Rep.; Gerald Mossinghoff, Pharmaceutical Research & Mfrs. of Amer.; Charles Cooper, Shaw, Pittman, Potts & Trowbridge; James Firman, Generic Drug Equity Coalition, & pres., Nat. Council of the Aging; Judith Simpson, United Patients' Assoc. for Pulmonary Hypertension; Robert Gunter, Nat. Pharm. Alliance, & Novo-Pharm; John Klein, Generic Pharm. Ind. Assoc.; Bruce Downey, Barr Labs.; Eran Broshy, Boston Consulting Group; David Beier, Genentech, for the Biotech. Industry Org.; Henry Grabowski, Duke Univ.; Daniel Perry, Alliance for Aging Research; & Dixie Horning, Gray Panthers.

No grāmatas satura

Bieži izmantoti vārdi un frāzes

Populāri fragmenti

183. lappuse - Congressional enactment of the Drug Price Competition and Patent Term Restoration Act of 1984 (PL 98-417).
254. lappuse - ... one of the most essential sticks in the bundle of rights that are commonly characterized as property.
190. lappuse - Subject to the payment of fees under this title, such grant shall be for a term beginning on the date on which the patent issues and ending 20 years from the date on which the application for the patent was filed...
87. lappuse - Except as otherwise provided in this title, whoever without authority makes, uses, offers to sell or sells any patented invention, within the United States or imports into the United States any patented invention during the term of the patent therefor, infringes the patent.
195. lappuse - The Office of Management and Budget advises that it has no objection to this report from the standpoint of the Administration's program.
107. lappuse - Thank you, Mr. Chairman, and thank you to the members of the committee for inviting me to submit testimony regarding the extension of the Voting Rights Act language assistance amendments.
87. lappuse - RNA, hybridoma technology, or other processes involving site specific genetic manipulation techniques) solely for uses reasonably related to the development and submission of information under a Federal law which regulates the manufacture, use, or sale of drugs or veterinary biological products.
255. lappuse - ... to those who entitle themselves to such grants. The Government of the United States, as well as the citizen, is subject to the Constitution; and when it grants a patent the grantee is entitled to it as a matter' of right, and does not receive it, as was originally supposed to be the case in England, as a matter of grace and favor.
267. lappuse - Upon finding for the claimant the court shall award the claimant damages adequate to compensate for the infringement but in no event less than a reasonable royalty for the use made of the invention by the infringer, together with interest and costs as fixed by the court.
67. lappuse - ... personal" right, whether the "property" in question be a welfare check, a home, or a savings account. In fact, a fundamental interdependence exists between the personal right to liberty and the personal right in property. Neither could have meaning without the other.

Bibliogrāfiskā informācija